Dermacyd Silver Floral (Lactic Acid) - Acceptability.

Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up Dermacyd Silver Floral (Lactic Acid).

Primary Objective:

To prove the safety of the gynaecological formulation in normal conditions of use.

Inclusion criteria:

• Integral vaginal mucosa in the product analysis region
• Use the same category of cosmetics products
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time

Exclusion criteria:

• Use of Anti-inflammatory, immunossupression or antihistaminics drugs
• Allergic or atopic history to cosmetics products
• Cutaneous active disease (local and/or general) in the evaluated area
• Disease which can cause immunosuppresion, such as diabetes, HIV
• Endocrinology pathology such as thyroid gland, ovary and adrenal gland
• Intensive solar exposure until 15 days before evaluation
• Gynecological treatment until four weeks before the study
• Other reason considered by the investigator as a reason for not being included.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.